T. Rowe Price Associates’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$117K Hold
27,036
﹤0.01% 2965
2025
Q4
$158K Buy
27,036
+5,649
+26% +$27.1K ﹤0.01% 2862
2025
Q3
$82K Hold
21,387
﹤0.01% 2956
2025
Q2
$77K Buy
+21,387
New +$60.7K ﹤0.01% 2942
2021
Q3
Sell
-14,100
Closed -$65K 2967
2021
Q2
$65K Sell
14,100
-1,926
-12% -$7.56K ﹤0.01% 2883
2021
Q1
$56K Buy
+16,026
New +$69.4K ﹤0.01% 2819

Other funds holding KRMD

T. Rowe Price Associates's KRMD Position: Q1 2026 in Review

T. Rowe Price Associates held its KORU Medical Systems (KRMD) position steady in Q1 2026 at 27,036 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #2965.

T. Rowe Price Associates first reported a position in KRMD in Q1 2021 and has held it in 6 quarters since. The position peaked at $158K in Q4 2025. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

  • T. Rowe Price Associates held 27,036 shares of KORU Medical Systems worth $117K as of Q1 2026.
  • T. Rowe Price Associates left its KORU Medical Systems share count unchanged in Q1 2026.
  • KORU Medical Systems made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2965 holding.
  • T. Rowe Price Associates first reported a position in KORU Medical Systems in Q1 2021 and has held it in 6 quarters since.
  • T. Rowe Price Associates's KORU Medical Systems position peaked at $158K in Q4 2025.
  • 91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.